Innoviva Entered into a Definitive Merger Agreement with Entasis Therapeutics
Shots: Innoviva to purchase all the remaining equity securities of Entasis for $2....
Emergent BioSolutions Entered into a Definitive Agreement with Chimerix to Acquire Tembexa (brincidofovir) Rights for Smallpox
Shots: Chimerix to receive $225M one-time up front in cash, ~$100...
KemPharm Signs a Definitive Agreement with Orphazyme to Acquire Arimoclomol for the Treatment of Niemann-Pick Disease Type C
Shots: KemPharm to acquire Orphazyme assets including Arimoclomol for $12.8M in ca...
Taiho Entered into an Agreement to Acquire Cullinan for CLN-081/TAS6417 to Treat EGFR Exon20 Non-Small Cell Lung Cancer
Shots: Cullinan to receive $275M up front, ~ $130M in regulatory-based milestones...
Cortexyme Entered into an Agreement to Acquire Novosteo for the Treatment of Rare Skeletal Diseases
Shots: Following the completion of the acquisition, Novosteo stockholders will own...
Pfizer to Acquire Biohaven for ~$11.6B
Shots: Pfizer to acquire all outstanding shares of Biohaven for $148.50/share in c...
